{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T05:36:23Z","timestamp":1761197783243,"version":"build-2065373602"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:00:00Z","timestamp":1622851200000},"content-version":"am","delay-in-days":400,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progr\u00e8s en Urologie"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.purol.2020.03.002","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T17:09:09Z","timestamp":1586452149000},"page":"353-364","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Les th\u00e9rapeutiques non chirurgicales de la maladie de Lapeyronie\u00a0: \u00e9tat des lieux des connaissances actuelles"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-2195","authenticated-orcid":false,"given":"M.","family":"Abdessater","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kanbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Coloby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Beley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Sleiman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0255","doi-asserted-by":"crossref","first-page":"280","DOI":"10.21037\/tau.2016.04.05","article-title":"Peyronie's disease: a literature review on epidemiology, genetics, pathophysiology, diagnosis and work-up","volume":"5","author":"Al-Thakafi","year":"2016","journal-title":"Transl Androl Urol"},{"issue":"4","key":"10.1016\/j.purol.2020.03.002_bib0260","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ucl.2007.08.017","article-title":"Peyronie's disease","volume":"34","author":"Taylor","year":"2007","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.purol.2020.03.002_bib0265","doi-asserted-by":"crossref","first-page":"282503","DOI":"10.1155\/2011\/282503","article-title":"A population-based study of Peyronie's disease: prevalence and treatment patterns in the United States","volume":"2011","author":"Dibenedetti","year":"2011","journal-title":"Adv Urol"},{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0270","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0022-5347(05)64578-8","article-title":"A retrospective review of 307\u00a0men with Peyronie's disease","volume":"168","author":"Kadioglu","year":"2002","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0275","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.jsxm.2016.04.062","article-title":"Evidence-based management guidelines on Peyronie's disease","volume":"13","author":"Chung","year":"2016","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0280","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0895-4356(98)00015-8","article-title":"A case-control study on risk factors for Peyronie's disease","volume":"51","author":"Carrieri","year":"1998","journal-title":"J Clin Epidemiol"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0285","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1111\/j.1743-6109.2009.01250.x","article-title":"Original research\u00a0\u2014\u00a0Peyronie's disease: testosterone deficiency and Peyronie's disease: Pilot data suggesting a significant relationship","volume":"6","author":"Moreno","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.03.002_bib0290","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1038\/sj.ijir.3901082","article-title":"Expanding the paradigm for plaque development in Peyronie's disease","volume":"15","author":"Mulhall","year":"2003","journal-title":"Int J Impot Res"},{"issue":"7","key":"10.1016\/j.purol.2020.03.002_bib0295","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: evidence-based 2010\u00a0guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0300","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S0090-4295(97)00238-0","article-title":"The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction","volume":"49","author":"Rosen","year":"1997","journal-title":"Urology"},{"issue":"2","key":"10.1016\/j.purol.2020.03.002_bib0305","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.juro.2013.01.090","article-title":"Bother and distress associated with Peyronie's disease: validation of the Peyronie's disease questionnaire","volume":"190","author":"Hellstrom","year":"2013","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.purol.2020.03.002_bib0310","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1743-6109.2008.00949.x","article-title":"Risk factors for emotional and relationship problems in Peyronie's disease","volume":"5","author":"Smith","year":"2008","journal-title":"J Sex Med"},{"issue":"1","key":"10.1016\/j.purol.2020.03.002_bib0315","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.juro.2013.01.087","article-title":"Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of Peyronie's disease in 2\u00a0large double-blind, randomized, placebo controlled phase 3\u00a0studies","volume":"190","author":"Gelbard","year":"2013","journal-title":"J Urol"},{"issue":"9273","key":"10.1016\/j.purol.2020.03.002_bib0320","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1016\/S0140-6736(00)05119-9","article-title":"Fran\u00e7ois de la Peyronie and the disease named after him","volume":"357","author":"Hauck","year":"2001","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.purol.2020.03.002_bib0325","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0022-5347(01)67529-3","article-title":"Value of magnetic resonance imaging in patients with penile induration (Peyronie's disease)","volume":"153","author":"Vosshenrich","year":"1995","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.purol.2020.03.002_bib0330","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s003450100209","article-title":"Management of Peyronie's disease\u2013a review","volume":"19","author":"Tunuguntla","year":"2001","journal-title":"World J Urol"},{"issue":"2","key":"10.1016\/j.purol.2020.03.002_bib0335","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.sxmr.2017.10.002","article-title":"Penile Length: measurement technique and applications","volume":"6","author":"Davoudzadeh","year":"2018","journal-title":"Sex Med Rev"},{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0340","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.eururo.2012.05.040","article-title":"EAU guidelines on penile curvature","volume":"62","author":"Hatzimouratidis","year":"2012","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.purol.2020.03.002_bib0345","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1743-6109.2006.00404.x","article-title":"Measurement of penile curvature in Peyronie's disease patients: comparison of three methods","volume":"4","author":"Ohebshalom","year":"2007","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.purol.2020.03.002_bib0350","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/BF03034477","article-title":"Valeur et place de l\u2019imagerie de la maladie de La Peyronie","volume":"8","author":"Schouman-Claeys","year":"1998","journal-title":"Andrologie"},{"issue":"2","key":"10.1016\/j.purol.2020.03.002_bib0355","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000019698","article-title":"Imaging modalities in Peyronie's disease. An intrapersonal comparison of ultrasound sonography, X-ray in mammography technique, computerized tomography, and nuclear magnetic resonance in 20\u00a0patients","volume":"34","author":"Andresen","year":"1998","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0360","first-page":"369","article-title":"Ultrasonography and radiography in the diagnosis of Peyronie's disease","volume":"41","author":"Pohar","year":"1990","journal-title":"Can Assoc Radiol J"},{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0365","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eururo.2007.07.013","article-title":"The natural history of Peyronie's disease: an ultrasonography-based study","volume":"53","author":"Bekos","year":"2008","journal-title":"Eur Urol"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0370","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1016\/S0022-5347(05)67525-8","article-title":"Evidence based assessment of long-term results of plaque incision and vein grafting for Peyronie's disease","volume":"163","author":"Montorsi","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.purol.2020.03.002_bib0375","first-page":"1","article-title":"Efficacy and safety evaluation of pentoxifylline associated with other antioxidants in medical treatment of Peyronie's disease: a case-control study","volume":"8","author":"Paulis","year":"2015","journal-title":"Res Reports Urol"},{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0380","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.juro.2015.05.098","article-title":"Peyronie's disease: AUA guideline","volume":"194","author":"Nehra","year":"2015","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2020.03.002_bib0385","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.5489\/cuaj.5255","article-title":"2018\u00a0Canadian Urological Association guideline for Peyronie's disease and congenital penile curvature","volume":"12","author":"Bella","year":"2018","journal-title":"Can Urol Assoc J"},{"issue":"4","key":"10.1016\/j.purol.2020.03.002_bib0390","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1016\/j.juro.2007.05.162","article-title":"Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study","volume":"178","author":"Safarinejad","year":"2007","journal-title":"J Uro"},{"key":"10.1016\/j.purol.2020.03.002_bib0395","first-page":"17","article-title":"Current and emerging treatment options for Peyronie's disease","volume":"5","author":"Gokce","year":"2013","journal-title":"Res reports Urol"},{"key":"10.1016\/j.purol.2020.03.002_bib0400","first-page":"37","article-title":"Vactosertib, a novel, orally bioavailable activin receptor-like kinase 5\u00a0inhibitor, promotes regression of fibrotic plaques in a rat model of Peyronie's disease","volume":"27","author":"Song","year":"2019","journal-title":"World J Mens Health"},{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0405","doi-asserted-by":"crossref","DOI":"10.4066\/2591-7951.1000052","article-title":"Treatment of scleroderma with para-aminobenzoic acid: effect on disease morbidity","volume":"2","author":"Sawalha","year":"2018","journal-title":"Arch Gen Intern Med"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0410","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1016\/S0022-5347(05)68087-1","article-title":"Tamoxifen versus placebo in the treatment of Peyronie's disease","volume":"162","author":"Teloken","year":"1999","journal-title":"J Urol"},{"issue":"5","key":"10.1016\/j.purol.2020.03.002_bib0415","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.acuro.2010.03.009","article-title":"Conservative treatment of Peyronie's disease: colchicine vs. colchicine plus vitamin E","volume":"34","author":"Cort\u00e9s-Gonz\u00e1lez","year":"2010","journal-title":"Actas Urol Esp"},{"issue":"2","key":"10.1016\/j.purol.2020.03.002_bib0420","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-410X.2009.09041.x","article-title":"A double-blind placebo-controlled study of the efficacy and safety of pentoxifylline in early chronic Peyronie's disease","volume":"106","author":"Safarinejad","year":"2009","journal-title":"BJU Int"},{"issue":"4","key":"10.1016\/j.purol.2020.03.002_bib0425","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrurol.2010.24","article-title":"Treatment of Peyronie's disease with PDE5\u00a0inhibitors: an antifibrotic strategy","volume":"7","author":"Gonzalez-Cadavid","year":"2010","journal-title":"Nat Rev Urol"},{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0430","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s11845-013-1036-5","article-title":"Effects of sildenafil treatment on patients with Peyronie's disease and erectile dysfunction","volume":"183","author":"Ozturk","year":"2014","journal-title":"Irish J Med Sci"},{"issue":"1","key":"10.1016\/j.purol.2020.03.002_bib0435","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1464-410x.2001.02241.x","article-title":"Acetyl-l-carnitine vs tamoxifen in the oral therapy of Peyronie's disease: a preliminary report","volume":"88","author":"Biagiotti","year":"2001","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.purol.2020.03.002_bib0440","first-page":"30","article-title":"Differential effects of pentoxifylline on the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) by monocytes and T cells","volume":"76","author":"Schanden\u00e9","year":"1992","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.purol.2020.03.002_bib0445","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.sxmr.2017.07.005","article-title":"Collagenase clostridium histolyticum in the treatment of Peyronie's disease\u00a0\u2014\u00a0a review of the literature and a new modified protocol","volume":"5","author":"Abdel Raheem","year":"2017","journal-title":"Sex Med Rev"},{"issue":"1","key":"10.1016\/j.purol.2020.03.002_bib0450","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1743-6109.2012.03003.x","article-title":"Standard operating procedures for Peyronie's disease","volume":"10","author":"Levine","year":"2013","journal-title":"J Sex Med"},{"issue":"11","key":"10.1016\/j.purol.2020.03.002_bib0455","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","article-title":"Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial","volume":"7","author":"Soh","year":"2010","journal-title":"J Sex Med"},{"issue":"2","key":"10.1016\/j.purol.2020.03.002_bib0460","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.2047-2927.2013.00181.x","article-title":"Adipose tissue-derived stem cell therapy for prevention and treatment of erectile dysfunction in a rat model of Peyronie's disease","volume":"2","author":"Gokce","year":"2014","journal-title":"Andrology"},{"key":"10.1016\/j.purol.2020.03.002_bib0465","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.eururo.2006.10.042","article-title":"Systematic Evidence-based analysis of plaque injection therapy for Peyronie's disease","volume":"51","author":"Russell","year":"2007","journal-title":"European Urology"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0470","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1016\/S0022-5347(05)64173-0","article-title":"Transdermal application of verapamil gel to the penile shaft fails to infiltrate the tunica albuginea","volume":"168","author":"Martin","year":"2002","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.purol.2020.03.002_bib0475","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/j.juro.2006.10.065","article-title":"Verapamil versus saline in electromotive drug administration for Peyronie's disease: a double-blind, placebo controlled trial","volume":"177","author":"Greenfield","year":"2007","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0480","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1111\/j.1743-6109.2007.00614.x","article-title":"Continuing medical education: Peyronie's disease (CME)","volume":"4","author":"Bella","year":"2007","journal-title":"J Sex Med"},{"issue":"6","key":"10.1016\/j.purol.2020.03.002_bib0485","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/02841860801910379","article-title":"Radiotherapy for Peyronie's disease: a European survey","volume":"47","author":"Incrocci","year":"2008","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.purol.2020.03.002_bib0490","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1743-6109.2008.01108.x","article-title":"Original research\u00a0\u2014\u00a0Peyronie's disease: use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study","volume":"6","author":"Gontero","year":"2009","journal-title":"J Sex Med"},{"issue":"11","key":"10.1016\/j.purol.2020.03.002_bib0495","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1111\/jsm.12312","article-title":"Baseline characteristics from an ongoing phase 3\u00a0study of collagenase clostridium histolyticum in patients with Peyronie's disease","volume":"10","author":"Gelbard","year":"2013","journal-title":"J Sex Med"},{"key":"10.1016\/j.purol.2020.03.002_bib0250","doi-asserted-by":"crossref","DOI":"10.1111\/bju.14784","article-title":"Optimizing collagenase clostridium histolyticum therapy for Peyronie's disease using a novel approach with percutaneous needle tunnelling","author":"Fern\u00e1ndez-Pascual","year":"2019","journal-title":"BJU Int"}],"container-title":["Progr\u00e8s en Urologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708720300944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1166708720300944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T06:32:46Z","timestamp":1761114766000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1166708720300944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S1166708720300944"],"URL":"https:\/\/doi.org\/10.1016\/j.purol.2020.03.002","relation":{},"ISSN":["1166-7087"],"issn-type":[{"type":"print","value":"1166-7087"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les th\u00e9rapeutiques non chirurgicales de la maladie de Lapeyronie\u00a0: \u00e9tat des lieux des connaissances actuelles","name":"articletitle","label":"Article Title"},{"value":"Progr\u00e8s en Urologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.purol.2020.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}